Search results for:
PACLitaxel protein-bound
PACLitaxel protein-bound
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| PACLitaxel (protein-bound) |
POWDER FOR INJECTION, INTRAVENOUS |
100 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Jul. 14, 2023
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of paclitaxel protein-bound injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet
Med Center
UNC Medical Center Formulary Restrictions